Wednesday, September 10, 2025 The CCTG 2024 Annual Report is now live! 2024 was a highly eventful year for the group, marked by both challenges and significant achievements. The group surpassed expectations in trial activation, launching 18 new studies across early and late phase programs—exceeding our annual target. Funding activity was also strong, with 17 applications submitted and seven successfully awarded, securing $5.9 million in support. Research productivity remained high, with 41 peer-reviewed publications, including several practice-changing papers featured in leading journals. Please take a moment to explore the achievements, committee overviews and key statistics from the past year, highlighting the impact of our research and commitment to improving outcomes for people with cancer. https://www.ctg.queensu.ca/images/1-public-pages/CCTG-2024AnnualReport-Final.pdf
